Evidence map›Paper›PMID 39513183›Full record

ArticleCase reports in oncology

SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report.

Yan Xiao, Jinwei Wang, Kai Yang, Meiling Jiang, Bo Zhang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan XiaoRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, China.
Jinwei WangRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, China.
Kai YangRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, China.
Meiling JiangRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, China.
Bo ZhangRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Investigation on virus-host interaction may provide new clues for antitumor immunotherapy. Case Presentation: In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission. Conclusion: Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based antitumor immune therapy in the future.

Indexed as

B-cell non-hodgkin lymphomaImmune cross-reactivitySARS-COV-2Tumor remission

Identifiers

PMID39513183
PMCPMC11542925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.